advertisement

WGA Rescources

11.5.2 Topical (7)

Showing records 1 to 7

Display all abstracts in classification 11.5.2 Topical

Search within classification 11.5.2 Topical
27471 Perspectives on carbonic anhydrase
Gilmour KM
Comparative Biochemistry and Physiology - A Molecular and Integrative Physiology 2010; 157: 193-197
27110 The additive effect of dorzolamide hydrochloride (Trusopt) and a morning dose of bimatoprost (Lumigan) on intraocular pressure and retrobulbar blood flow in patients with primary open-angle glaucoma
Stankiewicz A; Wierzbowska J; Siemiatkowska A; Fuksinska B; Robaszkiewicz J; Zegadlo A; Ehrlich R; Siesky B; Harris A
British Journal of Ophthalmology 2010; 94: 1307-1311
27000 Contrast sensitivity and optical quality of the eye after instillation of timolol maleate gel-forming solution and brinzolamide ophthalmic suspension.
Hiraoka T; Daito M; Okamoto F; Kiuchi T; Oshika T
Ophthalmology 2010; 117: 2080-2087
27400 Intraocular pressure-lowering efficacy of brinzolamide when added to travoprost/timolol fixed combination as adjunctive therapy
Goldberg I; Crowston JG; Jasek MC; Stewart JA; Stewart WC
Journal of Glaucoma 2010;
27355 Ocular pharmacokinetics of methazolamide ophthalmic suspension in rabbit aqueous humor
Liu W; Gan Y; Gan L; Ping Q-N; Cao F; Xiao Y-Y
Journal of China Pharmaceutical University 2010; 41: 337-341
27323 Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: Formulation of dorzolamide eye drop microparticle suspension
Jansook P; Stefansson E; Thorsteinsdottir M; Sigurdsson BB; Kristjansdottir SS; Bas JF; Sigurdsson HH; Loftsson T
European Journal of Pharmaceutics and Biopharmaceutics 2010; 76: 208-214
27264 Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide
Qian Y; Wang F; Li R; Zhang Q; Xu Q
Drug Development and Industrial Pharmacy 2010; 36: 1340-1347

Issue 12-4

Change Issue


advertisement

Oculus